Table 1.
Sociodemographic Factors and Co-Infection Statuses among Persons who inject drugs (PWID) and Healthy Volunteers in Estonia
| PWID (n = 345) |
Healthy volunteers (n = 138) |
|
|---|---|---|
| Gender, n (%) | ||
| Male | 272 (79%) | 59 (43%) |
| Age, median (IQR) | 30 (25–34) | 38 (27–51) |
| Duration of injection drug use, median (IQR) |
11 (7–14) | NA |
| Receptively shared needles, n (%) | ||
| Evera | 220 (64%) | NA |
| Frequentlyb | 61 (18%) | NA |
| HIV status, n (%) | ||
| HIV+ | 172 (50%) | 0 |
| HCV status, n (%) | ||
| HCV+ | 306 (89%) | 0 |
| HBV status, n (%) | ||
| HBV+ | 232 (67%) | 0 |
| HBV vaccinated | 43 (12%) | 39 (28%) |
| HTLV-1 status, n (%) | ||
| HTLV-1+ | 0 | 0 |
| HTLV-2 status, n (%) | ||
| HTLV-2+ | 1 (0.003%) | 0 |
Note.
a
reported receptive needle sharing in the past.
b
reported receptive needle sharing at least once a month during last six months.